These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28315905)

  • 1. Breast-specific gamma camera imaging with
    Zhang A; Li P; Liu Q; Song S
    Hell J Nucl Med; 2017; 20(1):26-35. PubMed ID: 28315905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis.
    Guo C; Zhang C; Liu J; Tong L; Huang G
    Nucl Med Commun; 2016 Jul; 37(7):675-88. PubMed ID: 26974314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-analysis and meta-regression.
    Xu HB; Li L; Xu Q
    Nucl Med Commun; 2011 Nov; 32(11):980-8. PubMed ID: 21956488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
    Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI.
    Kim BS
    Ann Nucl Med; 2012 Feb; 26(2):131-7. PubMed ID: 22006539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging.
    Yoon HJ; Kim Y; Lee JE; Kim BS
    Eur Radiol; 2015 Jan; 25(1):32-40. PubMed ID: 25216768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
    Tan H; Zhang H; Yang W; Fu Y; Gu Y; Du M; Cheng D; Shi H
    Nucl Med Commun; 2016 Aug; 37(8):792-9. PubMed ID: 27058361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study.
    Brem RF; Fishman M; Rapelyea JA
    Acad Radiol; 2007 Aug; 14(8):945-50. PubMed ID: 17659240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast-specific gamma imaging with 99mTc-Sestamibi and magnetic resonance imaging in the diagnosis of breast cancer--a comparative study.
    Brem RF; Petrovitch I; Rapelyea JA; Young H; Teal C; Kelly T
    Breast J; 2007; 13(5):465-9. PubMed ID: 17760667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women.
    Yu X; Hu G; Zhang Z; Qiu F; Shao X; Wang X; Zhan H; Chen Y; Deng Y; Huang J
    BMC Cancer; 2016 Jul; 16():450. PubMed ID: 27401536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients.
    Lee HS; Ko BS; Ahn SH; Son BH; Lee JW; Kim HJ; Yu JH; Kim SB; Jung KH; Ahn JH; Cha JH; Kim HH; Lee HJ; Song IH; Gong G; Park SH; Lee JJ; Moon DH
    Breast Cancer Res Treat; 2014 May; 145(1):91-100. PubMed ID: 24671359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescintigraphic morphine application for abdominal adenocarcinoma imaging, with technetium-99m methoxy isobutyl isonitrile.
    Ferlitsch A; Steindl-Munda P; Haefner M; Peck-Radosavljevic M; Madl C; Pötzi R; Homoncik M; Weidekamm C; Granegger S; Sinzinger H
    Hell J Nucl Med; 2007; 10(1):14-8. PubMed ID: 17450244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging.
    Ozülker T; Ozülker F; Ozpaçaci T; Bender O; Değirmenci H
    Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Technetium-99m Methoxy-Isobutyl-Isonitrile for Differentiation of Malignant Thyroid Nodules: A Systematic Review and Meta-Analysis.
    Kim SJ; Lee SW; Jeong SY; Pak K; Kim K
    Thyroid; 2018 Oct; 28(10):1339-1348. PubMed ID: 30129898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-specific gamma imaging is a cost effective and efficacious imaging modality when compared with MRI.
    Johnson N; Sorenson L; Bennetts L; Winter K; Bryn S; Johnson W; Glissmeyer M; Garreau J; Blanchard D
    Am J Surg; 2014 May; 207(5):698-701; discussion 701. PubMed ID: 24791629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added value of semi-quantitative breast-specific gamma imaging in the work-up of suspicious breast lesions compared to mammography, ultrasound and 3-T MRI.
    Meissnitzer T; Seymer A; Keinrath P; Holzmannhofer J; Pirich C; Hergan K; Meissnitzer MW
    Br J Radiol; 2015 Jul; 88(1051):20150147. PubMed ID: 25882690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer.
    Liu T; Cheng T; Xu W; Yan WL; Liu J; Yang HL
    Skeletal Radiol; 2011 May; 40(5):523-31. PubMed ID: 20495798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
    Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
    Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.